News & Updates

MSP Long-term supervised exercise works better than usual care in RA
MSP Long-term supervised exercise works better than usual care in RA
04 Oct 2024

For people with rheumatoid arthritis (RA) and severe functional limitations, undergoing supervised exercise therapy for more than 52 weeks results in better outcomes compared with usual care, as reported in a study.

MSP Long-term supervised exercise works better than usual care in RA
04 Oct 2024
MSP Abatacept may mitigate rheumatoid arthritis development in at-risk individuals
MSP Abatacept may mitigate rheumatoid arthritis development in at-risk individuals
03 Oct 2024
Adalimumab concentrations negatively linked to inflammatory markers in RA
Adalimumab concentrations negatively linked to inflammatory markers in RA
22 Jul 2024

A negative association exists between adalimumab (ADA) concentrations and markers of inflammatory disease activity in rheumatoid arthritis (RA), including interleukin 6 (IL-6), reveals a study. Notably, ADA concentrations from 5 to 7 mg/L over the dose interval seem to contribute to better disease control.

Adalimumab concentrations negatively linked to inflammatory markers in RA
22 Jul 2024